Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07663695Not yet recruiting
Randomised, double-blind trial of ciprofol in hypotension (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Incidence of post-induction hypotension. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07663695.